Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
DBV Technologies S.A. - American Depositary Shares
(NQ:
DBVT
)
7.700
+1.240 (+19.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DBV Technologies S.A. - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
Next >
Why Shares of DBV Technologies Jumped Thursday
May 11, 2023
The New England Journal of Medicine reported phase 3 trial details regarding the company's peanut allergy treatment for toddlers.
Via
The Motley Fool
Good News For Toddlers With Peanut Allergy: DBVT Data Shows Promising Results for Peanut Allergy Patch
May 11, 2023
DBV Technologies (NASDAQ: DBVT) (OTC:
Via
Benzinga
DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut in Toddlers
May 10, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Participate in Upcoming Investor Conference
May 09, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Reports First Quarter 2023 Financial Results
May 04, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Earnings Preview: DBV Technologies
March 01, 2023
Via
Benzinga
Why DBV Technologies Stock Is Soaring Today
December 23, 2022
The company can now move forward with a late-stage study of its lead pipeline candidate.
Via
The Motley Fool
DBV Technologies Outlines Regulatory Path For Viaskin Peanut Allergy Patch For Kids Below 3 Years
April 20, 2023
DBV Technologies (NASDAQ: DBVT) received written responses from the FDA on the regulatory path for the investigational Viaskin Peanut 250 μg patch (DBV712) in toddlers ages 1 – 3 years old with a...
Via
Benzinga
DBV Technologies Outlines Regulatory Path for Viaskin Peanut in Children 1 – 3 Years After Receiving Pre-BLA Responses from FDA
April 19, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Announces Results of its 2023 Ordinary and Extraordinary General Meeting
April 12, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
7 Penny Stocks Sitting in the Sweet Spot
March 26, 2023
If you can handle the ever-present threat of extreme volatility, these analyst-supported penny stocks could be interesting.
Via
InvestorPlace
Ordinary and Extraordinary General Meeting of April 12, 2023
March 24, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Update
March 13, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 08, 2023
Via
Benzinga
DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old
March 07, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies announces filing of 2022 Annual Report on Form 10-K and 2022 Universal Registration Document
March 02, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies Reports Full Year 2022 Financial Results and Business Update
March 02, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Report Full Year 2022 Financial Results and Business Updates on March 2, 2023
February 27, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Participate in Upcoming AAAAI 2023 Congress
February 21, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
DBV Technologies to Participate in Upcoming Investor Conference
February 10, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
January 23, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2022
January 04, 2023
From
DBV Technologies S.A.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
December 26, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 26, 2022
Via
Benzinga
Dow Rises 150 Points; Mission Produce Shares Slide
December 23, 2022
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Friday.
Via
Benzinga
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
December 23, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 23, 2022
Via
Benzinga
Dow Surges Over 100 Points; Crude Oil Rises Sharply
December 23, 2022
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 100 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 23, 2022
Via
Benzinga
Why DBV Technologies Shares Are Trading Higher By 38%; Here Are 26 Stocks Moving Premarket
December 23, 2022
Gainers Expion360 Inc. (NASDAQ: XPON) shares rose 152% to $2.47 in pre-market trading. Expion360 been selected as the exclusive supplier of high-energy lithium ion batteries for an overland trailer...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.